PapersFlow Research Brief
Reproductive Health and Contraception
Research Guide
What is Reproductive Health and Contraception?
Reproductive health and contraception encompasses the study of contraceptive methods to prevent unintended pregnancies, alongside factors influencing reproductive outcomes including effectiveness, safety, global trends in unintended pregnancy, maternal and child health impacts, and societal aspects of family planning and abortion.
The field includes 82,040 published works focused on contraception, unintended pregnancy prevention, and reproductive health outcomes. Key areas cover effectiveness and safety of methods like hormonal contraceptives, emergency contraception, and long-acting reversible contraception, as well as contraceptive failure rates. Research addresses global trends in unintended pregnancy and disparities across populations.
Topic Hierarchy
Research Sub-Topics
Long-Acting Reversible Contraception
This sub-topic evaluates efficacy, safety, and uptake of LARCs like IUDs and implants in diverse populations. Researchers address barriers including myths and provider biases.
Unintended Pregnancy Epidemiology
This sub-topic tracks global and national trends, disparities, and determinants of unintended pregnancies. Researchers analyze demographic surveys and project health impacts.
Hormonal Contraceptive Safety
This sub-topic assesses risks of venous thromboembolism, cardiovascular events, and mood effects with combined pills and progestins. Researchers conduct cohort studies and meta-analyses.
Emergency Contraception Effectiveness
This sub-topic examines levonorgestrel and ulipristal regimens, timing windows, and mechanisms like ovulation inhibition. Researchers study real-world use and BMI effects.
Contraceptive Failure Rates
This sub-topic analyzes method-specific failure probabilities, perfect vs typical use, and predictors like age and consistency. Researchers model cumulative risks using prospective data.
Why It Matters
Declines in unintended pregnancy rates in the United States from 2008 to 2011, documented by Finer and Zolna (2016) in "Declines in Unintended Pregnancy in the United States, 2008–2011", highlight the role of improved contraceptive access in reducing rates among poor and cohabiting women, though disparities persist. Trussell (2011) in "Contraceptive failure in the United States" quantifies failure rates for methods like condoms and oral contraceptives, informing public health strategies to lower unintended pregnancies that numbered over 45% of U.S. pregnancies in earlier periods. Curtis et al. (2016) in "U.S. Medical Eligibility Criteria for Contraceptive Use, 2016" provide guidelines for safe contraceptive use in women with medical conditions, enabling tailored family planning in clinical settings. Finer and Henshaw (2006) in "Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001" show higher rates among lower-income and minority groups, guiding targeted interventions in reproductive health services.
Reading Guide
Where to Start
"Declines in Unintended Pregnancy in the United States, 2008–2011" by Finer and Zolna (2016) provides an accessible entry point with clear data on U.S. trends and demographic patterns in unintended pregnancies.
Key Papers Explained
Finer and Zolna (2016) in "Declines in Unintended Pregnancy in the United States, 2008–2011" builds on earlier disparity analysis by Finer and Henshaw (2006) in "Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001", showing declines but persistent inequities. Trussell (2011) in "Contraceptive failure in the United States" supplies failure rate data underpinning both studies' pregnancy rate calculations. Curtis et al. (2016) in "U.S. Medical Eligibility Criteria for Contraceptive Use, 2016" offers clinical guidance to reduce failures identified by Trussell. Schulz (1995) in "Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials" warns of biases in trials evaluating these contraceptives.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints show no new developments in the last 6 months. News coverage lacks updates in the past 12 months. The field relies on established guidelines like those from Curtis et al. (2016).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Empirical evidence of bias. Dimensions of methodological quali... | 1995 | JAMA | 5.6K | ✕ |
| 2 | Empirical Evidence of Bias | 1995 | JAMA | 5.5K | ✕ |
| 3 | Sexually transmitted diseases treatment guidelines (2015) | 2015 | Reproductive Endocrino... | 2.7K | ✓ |
| 4 | Sexually transmitted diseases treatment guidelines | 2003 | Current Opinion in Ped... | 2.1K | ✕ |
| 5 | Declines in Unintended Pregnancy in the United States, 2008–2011 | 2016 | New England Journal of... | 1.9K | ✓ |
| 6 | Maternal age and fetal loss: population based register linkage... | 2000 | BMJ | 1.7K | ✓ |
| 7 | Chlamydia, gonorrhoea, trichomoniasis and syphilis: global pre... | 2019 | Bulletin of the World ... | 1.6K | ✓ |
| 8 | Contraceptive failure in the United States | 2011 | Contraception | 1.6K | ✓ |
| 9 | Disparities in Rates of Unintended Pregnancy In the United Sta... | 2006 | Perspectives on Sexual... | 1.5K | ✕ |
| 10 | U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 | 2016 | MMWR Recommendations a... | 1.4K | ✓ |
Frequently Asked Questions
What are the U.S. Medical Eligibility Criteria for Contraceptive Use?
The U.S. Medical Eligibility Criteria for Contraceptive Use, outlined by Curtis et al. (2016) in "U.S. Medical Eligibility Criteria for Contraceptive Use, 2016", offers recommendations for using specific contraceptive methods by women and men with certain characteristics or medical conditions. These CDC-updated guidelines assist health care providers in selecting safe options based on individual health profiles. They cover methods like hormonal contraceptives and long-acting reversible contraception across various conditions.
How have unintended pregnancy rates changed in the United States?
Finer and Zolna (2016) in "Declines in Unintended Pregnancy in the United States, 2008–2011" report a substantial decline in unintended pregnancy rates between 2008 and 2011 after a period of minimal change. Rates remained highest among poor women and girls and those cohabiting. This shift underscores the impact of contraceptive use on reproductive outcomes.
What are typical contraceptive failure rates in the United States?
Trussell (2011) in "Contraceptive failure in the United States" details failure rates for common methods, such as higher perfect-use versus typical-use failures for condoms and oral contraceptives. These rates contribute to overall unintended pregnancy statistics. The data supports education on consistent and correct use to minimize failures.
What disparities exist in unintended pregnancy rates?
Finer and Henshaw (2006) in "Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001" found unintended pregnancy rates highest among lower-income, minority, and younger women between 1994 and 2001. These disparities persisted across periods studied. Targeting services to these groups addresses inequities in reproductive health.
How does maternal age affect fetal loss?
Andersen (2000) in "Maternal age and fetal loss: population based register linkage study" shows high fetal loss rates in women aged 35 and older, regardless of reproductive history. This finding informs pregnancy planning and counseling. Women in late 30s or older face elevated risks independent of prior pregnancies.
What do guidelines say about treating sexually transmitted diseases?
Workowski and Bolan (2015) in "Sexually transmitted diseases treatment guidelines (2015)" update CDC recommendations for treating STDs like chlamydia and gonorrhea, consulted with experts in 2013. These guidelines target individuals at risk or infected. Providers use them to prevent complications linked to reproductive health.
Open Research Questions
- ? What factors drive persistent disparities in unintended pregnancy rates across socioeconomic groups despite overall declines?
- ? How do methodological biases in controlled trials affect estimates of contraceptive effectiveness and safety?
- ? What are the long-term health impacts of long-acting reversible contraception versus shorter-term methods?
- ? How do global prevalence estimates of curable STDs influence contraception and family planning strategies?
- ? What role does pregnancy intention play in maternal age-related fetal loss risks?
Recent Trends
The cluster holds 82,040 works with no specified 5-year growth rate.
No recent preprints from the last 6 months or news coverage in the past 12 months indicate steady reliance on foundational papers like Finer and Zolna on U.S. unintended pregnancy declines.
2016Research Reproductive Health and Contraception with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Reproductive Health and Contraception with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers